We are live on ! Find out more
Alkeon Capital Management

Alkeon Capital Management Portfolio holdings

AUM $59.5B
1-Year Est. Return 51.63%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$55.9B
AUM Growth
-$1.25B
Cap. Flow
-$23.2M
Cap. Flow %
-0.04%
Top 10 Hldgs %
73.88%
Holding
121
New
5
Increased
28
Reduced
37
Closed
20

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$192M
2
DELL icon
Dell
DELL
+$180M
3
ADBE icon
Adobe
ADBE
+$157M
4
AMZN icon
Amazon
AMZN
+$145M
5
DDOG icon
Datadog
DDOG
+$138M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$216M
2
MSFT icon
Microsoft
MSFT
+$182M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$158M
4
SNPS icon
Synopsys
SNPS
+$156M
5
BILL icon
BILL Holdings
BILL
+$146M

Sector Composition

Rank Sector Weight
1 Technology 10.88%
2 Communication Services 6.48%
3 Consumer Discretionary 4.87%
4 Financials 2.35%
5 Healthcare 0.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
76
Sarepta Therapeutics
SRPT
$1.76B
$55.6M 0.1%
458,845
-50,000
-10% -$5.65M
SMAR
77
DELISTED
Smartsheet Inc.
SMAR
$54.1M 0.1%
1,337,283
-909,000
-40% -$37.3M
KROS icon
78
Keros Therapeutics
KROS
$215M
$53.4M 0.1%
1,676,522
BPMC
79
DELISTED
Blueprint Medicines
BPMC
$47.4M 0.08%
943,928
RYTM icon
80
Rhythm Pharmaceuticals
RYTM
$8B
$39.5M 0.07%
1,725,167
JD icon
81
CALL
JD.com
JD
$44.9B
$36.3M 0.07%
1,247,000
-750,000
-38% -$26.1M
MQ icon
82
Marqeta
MQ
$1.66B
$30.8M 0.06%
1,288,776
+625,000
+94% +$14.2M
CTAS icon
83
Cintas
CTAS
$81.2B
$28.5M 0.05%
237,196
XYZ
84
Block Inc
XYZ
$47.9B
$25.5M 0.05%
576,000
+176,000
+44% +$10.9M
ORIC icon
85
Oric Pharmaceuticals
ORIC
$1.4B
$21M 0.04%
3,479,289
+500,000
+17% +$4.1M
XMTR icon
86
Xometry
XMTR
$5.25B
$18.7M 0.03%
1,101,989
STEM icon
87
Stem
STEM
$50.5M
$16.5M 0.03%
194,431
+50,000
+35% +$5.71M
PMVP icon
88
PMV Pharmaceuticals
PMVP
$64M
$14.4M 0.03%
2,347,414
+867,547
+59% +$5.96M
BCRX icon
89
BioCryst Pharmaceuticals
BCRX
$2.46B
$11.8M 0.02%
1,672,313
ETNB
90
DELISTED
89bio
ETNB
$10.8M 0.02%
700,000
KLRS
91
Kalaris Therapeutics
KLRS
$95.4M
$9.9M 0.02%
200,222
AAPL icon
92
Apple
AAPL
$4.47T
$9.7M 0.02%
56,627
CRBU icon
93
Caribou Biosciences
CRBU
$164M
$7.86M 0.01%
1,644,863
+287,800
+21% +$1.79M
MREO
94
Mereo BioPharma
MREO
$46.8M
$4.82M 0.01%
3,738,100
SONY icon
95
Sony
SONY
$140B
$4.53M 0.01%
275,000
FROG icon
96
JFrog
FROG
$10.5B
$366K ﹤0.01%
14,425
-594,460
-98% -$16.5M
AXP icon
97
American Express
AXP
$229B
-25,000
Closed -$4.36M
BILL icon
98
BILL Holdings
BILL
$4.82B
-1,250,311
Closed -$146M
BILL icon
99
PUT
BILL Holdings
BILL
$4.82B
-2,200,000
Closed -$257M
BJ icon
100
BJs Wholesale Club
BJ
$12.3B
-110,000
Closed -$6.93M

Similar funds

Alkeon Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Alkeon Capital Management held 121 positions worth $55.9B, down 2.2% from $57.2B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Alkeon Capital Management's Q3 2023 filing shows 5 new, 28 increased, 37 reduced and 20 closed positions. Its largest new stake was Adobe: 300,000 shares worth $153M. The largest sale was Alibaba, an estimated $216M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Alkeon Capital Management's largest Q3 2023 buy was Adobe: 300,000 shares worth $153M.
  • Alkeon Capital Management added most to KLA in Q3 2023, an estimated $192M increase.
  • Alkeon Capital Management's biggest Q3 2023 reduction was Alibaba, cutting an estimated $216M.
  • Alkeon Capital Management fully exited Invesco QQQ Trust in Q3 2023, selling an estimated $158M.
  • Alkeon Capital Management's ten largest holdings make up 74% of its $55.9B portfolio in Q3 2023.
  • Alkeon Capital Management opened 5 new positions and closed 20 in Q3 2023.
  • Alkeon Capital Management's portfolio value fell 2.2% quarter-over-quarter to $55.9B.

Based on Alkeon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.